<DOC>
	<DOC>NCT01621347</DOC>
	<brief_summary>The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.</brief_summary>
	<brief_title>Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women</brief_title>
	<detailed_description>Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care &amp; community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Pregnant Women HIVpositive Antiretroviral medication delivered in electronical monitors Monitored period during pregnancy &lt; 1 month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Postpartum</keyword>
	<keyword>Women</keyword>
	<keyword>Medication Adherence</keyword>
</DOC>